279 related articles for article (PubMed ID: 21486727)
1. Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Sandherr M; Maschmeyer G
Eur J Med Res; 2011 Apr; 16(4):139-44. PubMed ID: 21486727
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
3. Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Karthaus M
Eur J Med Res; 2011 Apr; 16(4):145-52. PubMed ID: 21486728
[TBL] [Abstract][Full Text] [Related]
4. Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.
Aperis G; Mylonakis E
Expert Opin Investig Drugs; 2006 Jun; 15(6):579-602. PubMed ID: 16732713
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole: review of a broad spectrum triazole antifungal agent.
Kofla G; Ruhnke M
Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
[TBL] [Abstract][Full Text] [Related]
6. [New antifungal agents: voriconazole and caspofungin].
Dupont B
Arch Pediatr; 2003 Dec; 10 Suppl 5():592s-598s. PubMed ID: 15022787
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.
Seyedmousavi S; Mouton JW; Verweij PE; Brüggemann RJ
Expert Rev Anti Infect Ther; 2013 Sep; 11(9):931-41. PubMed ID: 24053274
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole : a review of its use in the management of invasive fungal infections.
Scott LJ; Simpson D
Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole.
Med Lett Drugs Ther; 2002 Jul; 44(1135):63-5. PubMed ID: 12138377
[No Abstract] [Full Text] [Related]
11. Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Beiras-Fernandez A; Bigdeli AK; Nickel T; Michel S; Ueberfuhr P; Reichart B; Kaczmarek I
Exp Clin Transplant; 2011 Aug; 9(4):279-83. PubMed ID: 21819376
[TBL] [Abstract][Full Text] [Related]
12. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
13. Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
Kobayashi K; Ogasawara M; Kiyama Y; Miyazono T; Kagawa K; Imai K; Hirano T; Kobayashi N; Tanimoto M; Kasai M
Acta Med Okayama; 2009 Aug; 63(4):213-6. PubMed ID: 19727206
[TBL] [Abstract][Full Text] [Related]
14. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
[TBL] [Abstract][Full Text] [Related]
15. Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.
Maschmeyer G; Haas A
Future Microbiol; 2006 Dec; 1(4):365-85. PubMed ID: 17661629
[TBL] [Abstract][Full Text] [Related]
16. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Perkhofer S; Lass-Flörl C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074
[TBL] [Abstract][Full Text] [Related]
17. Voriconazole: in the treatment of invasive aspergillosis.
Muijsers RB; Goa KL; Scott LJ
Drugs; 2002; 62(18):2655-64; discussion 2665-6. PubMed ID: 12466006
[TBL] [Abstract][Full Text] [Related]
18. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
19. New antifungal drugs and the pediatric cancer patient: current status of clinical development.
Groll AH; Lehrnbecher T
Klin Padiatr; 2005; 217(3):158-68. PubMed ID: 15858708
[TBL] [Abstract][Full Text] [Related]
20. Voriconazole: a new triazole antifungal agent.
Pearson MM; Rogers PD; Cleary JD; Chapman SW
Ann Pharmacother; 2003 Mar; 37(3):420-32. PubMed ID: 12639175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
